Etiology and treatment of cancer-related secondary lymphedema.
Cancer-related lymphedema
Exercise
Genetics
Lymphedema
Surgical
Treatment
Journal
Clinical & experimental metastasis
ISSN: 1573-7276
Titre abrégé: Clin Exp Metastasis
Pays: Netherlands
ID NLM: 8409970
Informations de publication
Date de publication:
30 Sep 2023
30 Sep 2023
Historique:
received:
01
06
2023
accepted:
28
08
2023
medline:
1
10
2023
pubmed:
1
10
2023
entrez:
30
9
2023
Statut:
aheadofprint
Résumé
Lymphedema and specifically cancer-related lymphedema is not the main focus for both patients and physicians dealing with cancer. Its etiology is an unfortunate complication of cancer treatment. Although lymphedema treatments have gained an appreciable consensus, many practitioners have developed and prefer their own specific protocols and this is especially true for conventional (manual) versus surgical treatments. This collection of presentations explores the incidence and genetics of cancer-related lymphedema, early detection and monitoring techniques, both conventional and operative treatment options, and the importance and role of exercise for patients with cancer-related lymphedema. These assembled presentations provide valuable insights into the challenges and opportunities presented by cancer-related lymphedema including the latest research, treatments, and exercises available to improve patient outcomes and quality of life.
Identifiants
pubmed: 37777696
doi: 10.1007/s10585-023-10232-8
pii: 10.1007/s10585-023-10232-8
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
International Society of Lymphology (2020) The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology 53:3–19
World Health Organization (2022) Lymphatic Filariasis. https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis .Last accessed May 15, 2023
Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A (2019) Cancer-associated secondary lymphoedema. Nat Rev Dis Primers 5(1):22. https://doi.org/10.1038/s41572-019-0072-5
doi: 10.1038/s41572-019-0072-5
pubmed: 30923312
Teunissen SC et al (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34:94–104
pubmed: 17509812
doi: 10.1016/j.jpainsymman.2006.10.015
Bernas M, Thiadens SRJ, Stewart P, Granzow J (2022) Secondary lymphedema from cancer therapy. Clin Exp Metastasis 39(1):239–247. https://doi.org/10.1007/s10585-021-10096-w
doi: 10.1007/s10585-021-10096-w
pubmed: 33950413
Tandra P, Kallam A, Krishnamurthy J (2019) Identification and management of lymphedema in patients with breast cancer. J Oncol Pract 15(5):255–262. https://doi.org/10.1200/JOP.18.00141
doi: 10.1200/JOP.18.00141
pubmed: 31009281
DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500–515. https://doi.org/10.1016/S1470-2045(13)70076-7
doi: 10.1016/S1470-2045(13)70076-7
pubmed: 23540561
Armer JM, Shook RP, Schneider MK et al (2020) A 5-year longitudinal study of self-reported lymphedema among breast cancer survivors. Breast Cancer Res Treat 180(1):21–31
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM (2010) Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116(22):5138–5149
pubmed: 20665892
doi: 10.1002/cncr.25458
Menezes MM, Bello MA, Millen E et al (2016) Breast reconstruction and risk of lymphedema after mastectomy: A prospective cohort study with 10 years of follow-up. J Plast Reconstr Aesthet Surg 69(9):1218–1226. https://doi.org/10.1016/j.bjps.2016.06.001
doi: 10.1016/j.bjps.2016.06.001
pubmed: 27373492
Armer JM, Ballman KV, McCall L et al (2019) Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer 27(2):495–503. https://doi.org/10.1007/s00520-018-4334-7
doi: 10.1007/s00520-018-4334-7
pubmed: 29980907
Armbrust R, Auletta V, Cichon G, Vercellino G, Yost K, Sehouli J (2023) Lymphedema after pelvic and para-aortic lymphadenectomy-results of a systematic evaluation in patients with cervical and endometrial carcinoma. Arch Gynecol Obstet 307:1557–1565. https://doi.org/10.1007/s00404-022-06779-8
doi: 10.1007/s00404-022-06779-8
pubmed: 36222950
Kuroda K, Yamamoto Y, Yanagisawa M et al (2017) Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study. BMC Women’s Health 17:50
pubmed: 28743274
pmcid: 5526302
doi: 10.1186/s12905-017-0403-1
Halaska MJ, Novackova M, Mala I et al (2010) A prospective study of postoperative lymphedema after surgery for cervical cancer. Int J Gynecol Cancer 20:900–904
pubmed: 20606541
doi: 10.1111/IGC.0b013e3181da29d0
Novackova M, Halaska MJ, Robova H et al (2012) A prospective study in detection of lower-limb lymphedema and evaluation of quality of life after vulvar cancer surgery. Int J Gynecol Cancer 22:1081–1088
pubmed: 22683942
doi: 10.1097/IGC.0b013e31825866d0
Kunitake T, Kakuma T, Ushijima K (2020) Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment. Int J Clin Oncol 25:963–971
pubmed: 31907719
pmcid: 7192861
doi: 10.1007/s10147-019-01608-6
Huang Y, Zhang F, Yang C et al (2020) Incidence and risk factors for lymphedema after lymph node dissection in gynecologic malignancies: a systematic review and meta-analysis. J Gynecol Oncol 31(1):e7
Clinckaert A, Callens K, Cooreman A et al (2022) The prevalence of lower limb and genital lymphedema after prostate cancer treatment: a systematic review. Cancers (Basel) 14(22):5667. https://doi.org/10.3390/cancers14225667
doi: 10.3390/cancers14225667
pubmed: 36428759
Chen T, Lin Y, Tan Q (2022) Risk factors for lower extremity lymphedema after inguinal lymphadenectomy in melanoma patients: a retrospective cohort study. Surg Open Sci 8:33–39. https://doi.org/10.1016/j.sopen.2022.02.001
doi: 10.1016/j.sopen.2022.02.001
pubmed: 35280121
pmcid: 8914217
Hyngstrom JR, Chiang YJ, Cromwell KD et al (2013) Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res 23(4):290–297. https://doi.org/10.1097/CMR.0b013e3283632c83
doi: 10.1097/CMR.0b013e3283632c83
pubmed: 23752305
Stubblefield MD, Weycker D (2023) Under recognition and treatment of lymphedema in head and neck cancer survivors - a database study. Support Care Cancer 31(4):229. https://doi.org/10.1007/s00520-023-07698-3
doi: 10.1007/s00520-023-07698-3
pubmed: 36952136
pmcid: 10188415
Jeans C, Brown B, Ward EC et al (2022) A prospective, longitudinal and exploratory study of head and neck lymphoedema and dysphagia following chemoradiotherapy for head and neck cancer. Dysphagia. https://doi.org/10.1007/s00455-022-10526-1
doi: 10.1007/s00455-022-10526-1
pubmed: 36309604
pmcid: 10326103
Bernas M (2013) Imaging of the lymphatic system. Lymphedema management: the comprehensive guide for practitioners, 3rd edn. Thieme, New York
Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, Stazzone AM (2000) Advances in imaging of lymph flow disorders. Radiographics 20(6):1697–1719
pubmed: 11112825
doi: 10.1148/radiographics.20.6.g00nv141697
Hassanein AH, Maclellan RA, Grant FD, Greene AK (2017) Diagnostic accuracy of lymphoscintigraphy for lymphedema and analysis of false-negative tests. Plast Reconstr Surg Glob Open 5(7):e1396. https://doi.org/10.1097/GOX.0000000000001396
doi: 10.1097/GOX.0000000000001396
pubmed: 28831342
pmcid: 5548565
Rasmussen JC, Kwon S, Sevick-Muraca EM, Cormier JN (2012) The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng 40:408–421. https://doi.org/10.1007/s10439-011-0476-1
doi: 10.1007/s10439-011-0476-1
pubmed: 22139396
Yamamoto T, Matsuda N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I (2011) The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg 128(4):314e–321e
pubmed: 21921744
doi: 10.1097/PRS.0b013e3182268da8
Yamamoto T, Yamamoto N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I (2011) Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg 128(4):941–947. https://doi.org/10.1097/PRS.0b013e3182268cd9
doi: 10.1097/PRS.0b013e3182268cd9
pubmed: 21681123
Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM (2020) The development and treatment of lymphatic dysfunction in cancer patients and survivors. Cancers (Basel) 12(8):2280. https://doi.org/10.3390/cancers12082280
doi: 10.3390/cancers12082280
pubmed: 32823928
Dori Y, Keller MS, Fogel MA, Rome JJ, Whitehead KK, Harris MA, Itkin M (2014) MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR 203:426–431
pubmed: 24848564
doi: 10.2214/AJR.13.11797
Dori Y (2016) Novel lymphatic imaging techniques. Tech Vasc Interv Radiol 19(4):255–261. https://doi.org/10.1053/j.tvir.2016.10.002
doi: 10.1053/j.tvir.2016.10.002
pubmed: 27993320
Rane S, Donahue PMC, Towse T, Ridner S, Chappell M, Jordi J, Gore J, Donahue MJ (2013) Clinical feasibility of noninvasive visualization of lymphatic flow with principles of spin labeling MR imaging: implications for lymphedema assessment. Radiology 269:893–902
pubmed: 23864103
doi: 10.1148/radiol.13120145
Brouillard P, Witte MH, Erickson RP et al (2021) Primary lymphoedema. Nat Rev Dis Primers 7:77. https://doi.org/10.1038/s41572-021-00309-7
doi: 10.1038/s41572-021-00309-7
pubmed: 34675250
Gordon K, Varney R, Keeley V, Riches K, Jeffery S, Van Zanten M, Mortimer P, Ostergaard P, Mansour S (2020) Update and audit of the St George’s classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis. J Med Genet 57(10):653–659. https://doi.org/10.1136/jmedgenet-2019-106084
doi: 10.1136/jmedgenet-2019-106084
pubmed: 32409509
Rockson SG (2022) Cancer-related lymphedema: primary or secondary? Lymphat Res Biol 20(6):579. https://doi.org/10.1089/lrb.2022.29134
doi: 10.1089/lrb.2022.29134
pubmed: 36537707
Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE (2008) HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 6:65–68
pubmed: 18564920
pmcid: 4298750
doi: 10.1089/lrb.2008.1524
Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE (2012) Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res 18(8):1–9
doi: 10.1158/1078-0432.CCR-11-2303
Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, Cooper BA, Elboim C, Neuhaus J, Schmidt BL, Smoot B, Aouizeratet BE (2013) Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS ONE 8(4):e60164
pubmed: 23613720
pmcid: 3629060
doi: 10.1371/journal.pone.0060164
Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, Abrams G, Dhruva A, Schmidt BL, Kober K, Merriman JD, Leutwyler H, Neuhaus J, Langford D, Smoot BJ, Aouizerat BE, Miaskowski C (2014) Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol 12(1):10–22
pubmed: 24502445
pmcid: 3961780
doi: 10.1089/lrb.2013.0024
Smoot B, Kober KM, Paul SM, Levine JD, Abrams G, Mastick J, Topp K, Conley YP, Miaskowski CA (2017) Potassium channel candidate genes predict the development of secondary lymphedema following breast cancer surgery. Nurs Res 66(2):85–94
pubmed: 28252570
pmcid: 5334662
doi: 10.1097/NNR.0000000000000203
Visser J, van Geel M, Cornelissen AJM, van der Hulst RRWJ, Qiu SS (2019) Breast cancer-related lymphedema and genetic predisposition: a systematic review of the literature. Lymphat Res Biol. https://doi.org/10.1089/lrb.2017.0083
doi: 10.1089/lrb.2017.0083
pubmed: 30358483
Kapellas N, Demiri E, Lampropoulos A, Dionyssiou D (2022) Genetic predisposition in cancer-related lymphedema: a systematic review. Lymphat Res Biol 20(5):478–487. https://doi.org/10.1089/lrb.2021.0081
doi: 10.1089/lrb.2021.0081
pubmed: 35029515
Yusof KM, Groen K, Rosli R, Abdullah M, Mahmud R, Avery-Kiejda KA (2022) Evaluation of circulating MicroRNAs and adipokines in breast cancer survivors with arm lymphedema. Int J Mol Sci 23(19):11359. https://doi.org/10.3390/ijms231911359
doi: 10.3390/ijms231911359
pubmed: 36232660
pmcid: 9570352
Koc M, Wald M, Varaliová Z, Ondrůjová B, Čížková T, Brychta M, Kračmerová J, Beranová L, Pala J, Šrámková V et al (2021) Lymphedema alters lipolytic, lipogenic, immune and angiogenic properties of adipose tissue: a hypothesis-generating study in breast cancer survivors. Sci Rep 11:8171
pubmed: 33854130
pmcid: 8046998
doi: 10.1038/s41598-021-87494-3
Lin S, Kim J, Lee MJ et al (2012) Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS One 7(12):e52021. https://doi.org/10.1371/journal.pone.0052021
doi: 10.1371/journal.pone.0052021
pubmed: 23272198
pmcid: 3525657
Gordon K, Moore M, Van Zanten M et al (2022) Case Report: Progressive central conducting lymphatic abnormalities in the RASopathies. Two case reports, including successful treatment by MEK inhibition. Front Genet 13:1001105. https://doi.org/10.3389/fgene.2022.1001105
doi: 10.3389/fgene.2022.1001105
pubmed: 36238151
pmcid: 9550924
Dori Y, Smith C, Pinto E et al (2020) Severe lymphatic disorder resolved with MEK inhibition in a patient with noonan syndrome and SOS1 mutation. Pediatrics 146(6):e20200167. https://doi.org/10.1542/peds.2020-0167
doi: 10.1542/peds.2020-0167
pubmed: 33219052
Herbst KL, Kahn LA, Iker E et al (2021) Standard of care for lipedema in the United States. Phlebology 36(10):779–796. https://doi.org/10.1177/02683555211015887
doi: 10.1177/02683555211015887
pubmed: 34049453
pmcid: 8652358
Duhon BH, Phan TT, Taylor SL, Crescenzi RL, Rutkowski JM (2022) Current mechanistic understandings of lymphedema and lipedema: tales of fluid, fat, and fibrosis. Int J Mol Sci 23(12):6621. https://doi.org/10.3390/ijms23126621
doi: 10.3390/ijms23126621
pubmed: 35743063
pmcid: 9223758
Al-Ghadban S, Cromer W, Allen M, Ussery C, Badowski M, Harris D, Herbst KL (2019) Dilated blood and lymphatic microvessels, angiogenesis, increased macrophages, and adipocyte hypertrophy in lipedema thigh skin and fat tissue. J Obesity. https://doi.org/10.1155/2019/8747461
doi: 10.1155/2019/8747461
von Atzigen J, Burger A, Grünherz L et al (2023) A comparative analysis to dissect the histological and molecular differences among lipedema, lipohypertrophy and secondary lymphedema. Int J Mol Sci 24(8):7591. https://doi.org/10.3390/ijms24087591
doi: 10.3390/ijms24087591
Bano G, Mansour S, Brice G et al (2010) Pit-1 mutation and lipoedema in a family. Exp Clin Endocrinol Diabetes 118(6):377–380. https://doi.org/10.1055/s-0029-1224154
doi: 10.1055/s-0029-1224154
pubmed: 19609847
Michelini S, Chiurazzi P, Marino V, Dell’Orco D, Manara E, Baglivo M et al (2020) Aldo-keto reductase 1C1 (AKR1C1) as the first mutated gene in a family with non-syndromic primary lipedema. Int J Mol Sci 21(17):6264. https://doi.org/10.3390/ijms21176264
doi: 10.3390/ijms21176264
pubmed: 32872468
pmcid: 7503355
Grigoriadis D, Sackey E, Riches K et al (2022) Investigation of clinical characteristics and genome associations in the “UK Lipoedema” cohort. PLoS One 17(10):e0274867. https://doi.org/10.1371/journal.pone.0274867
doi: 10.1371/journal.pone.0274867
pubmed: 36227936
pmcid: 9560129
McLauglin SA et al (2013) Trends in risk reduction practices for the prevention of lymphedema in the first 12 month after breast cancer surgery. J Am Coll Surg 216(3):380–389
doi: 10.1016/j.jamcollsurg.2012.11.004
McEvoy MP, Ravetch E, Patel G, Fox J, Feldman S (2021) Prevention of breast cancer-related lymphedema. Clin Breast Cancer 21(2):128–142. https://doi.org/10.1016/j.clbc.2021.02.009
doi: 10.1016/j.clbc.2021.02.009
pubmed: 33771439
Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92(6):1368–1377. https://doi.org/10.1002/1097-0142(20010915)92:6%3c1368::aid-cncr1459%3e3.0.co;2-9
doi: 10.1002/1097-0142(20010915)92:6<1368::aid-cncr1459>3.0.co;2-9
pubmed: 11745212
Mc Laughlin SA et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol 26:5220–5226
pubmed: 18838708
doi: 10.1200/JCO.2008.16.3766
Ridner SH et al (2022) A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphat Res Biol 20(6):618–628
pubmed: 35099283
pmcid: 9810346
doi: 10.1089/lrb.2021.0084
McLaughlin SA et al (2017) Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel: Part 1: Definitions, Assessments, Education, and Future Directions. Ann Surg Oncol 24(10):2818–2826
pubmed: 28766232
doi: 10.1245/s10434-017-5982-4
Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN (2015) Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 65(1):55–81. https://doi.org/10.3322/caac.21253
doi: 10.3322/caac.21253
pubmed: 25410402
Deban M et al (2022) Higher rate of lymphedema with inguinal versus axillary complete lymph node dissection for melanoma: a potential target for immediate lymphatic reconstruction? Curr Oncol 29(8):5655–5663. https://doi.org/10.3390/curroncol29080446
doi: 10.3390/curroncol29080446
pubmed: 36005184
pmcid: 9406378
Dean LT et al (2019) Drivers of cost differences between US breast cancer survivors with or without lymphedema. J Cancer Surviv 13(5):804–814. https://doi.org/10.1007/s11764-019-00799-1
doi: 10.1007/s11764-019-00799-1
pubmed: 31446591
pmcid: 6828620
National Lymphedema Network (2012) Lymphedema Risk Reduction Practices. https://static1.squarespace.com/static/5b741fa71aef1d1e6500b325/t/621c4ad5d985833faafd332a/1646021333750/Risk+Reduction.pdf . Accessed May 20, 2023
McLaughlin SA, Stout NL, Schaverien MV (2020) Avoiding the swell: advances in lymphedema prevention, detection, and management. Am Soc Clin Oncol Educ Book 40:1–10. https://doi.org/10.1200/EDBK_280471
doi: 10.1200/EDBK_280471
pubmed: 32315238
Földi M, Földi E, Strößenreuther R, Kubik S (eds) (2012) Földi’s textbook of lymphology: for physicians and lymphedema therapists. Elsevier, San Francisco
Koelmeyer LA, Thompson BM, Mackie H et al (2021) Personalizing conservative lymphedema management using indocyanine green-guided manual lymphatic drainage. Lymphat Res Biol 19(1):56–65
pubmed: 33270517
doi: 10.1089/lrb.2020.0090
Godette K, Mondry TE, Johnstone PA (2006) Can manual treatment of lymphedema promote metastasis. J Soc Integr Oncol 4(1):8–12
pubmed: 16737666
Langevin HM, Keely P, Mao J et al (2016) Connecting (T) issues: how research in fascia biology can impact integrative oncology connective tissue research and integrative oncology. Can Res 76(21):6159–6162
doi: 10.1158/0008-5472.CAN-16-0753
Gordon P, Widener JM, Heffline M (2015) Venous leg ulcers: impact and dysfunction of the venous system. J Vasc Nurs 33(2):54–59
pubmed: 26025148
doi: 10.1016/j.jvn.2015.01.002
Byeon K, Choi JO, Yang JH et al (2012) The response of the vena cava to abdominal breathing. J Altern Complement Med 18(2):153–157
pubmed: 22339104
doi: 10.1089/acm.2010.0656
Russo MA, Santarelli DM, O’Rourke D (2017) The physiological effects of slow breathing in the healthy human. Breathe 13(4):298–309
pubmed: 29209423
pmcid: 5709795
doi: 10.1183/20734735.009817
Albasini A, Krause M, Rembitzki IV (2010) Using whole body vibration in physical therapy and sport E-Book: clinical practice and treatment exercises. Elsevier, Edinburgh
Merriman H, Jackson K (2009) The effects of whole-body vibration training in aging adults: a systematic review. J Geriatric Phys Therapy 32(3):134–145
doi: 10.1519/00139143-200932030-00009
Mortimer PS, Rockson SG (2014) New developments in clinical aspects of lymphatic disease. J Clin Investig 124(3):915–921
pubmed: 24590276
pmcid: 3938261
doi: 10.1172/JCI71608
Wilburn O, Wilburn P, Rockson SG (2006) A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer 6(1):1–10
doi: 10.1186/1471-2407-6-84
Brorson H, Svensson B, Ohlin K (2015) Suction-assisted lipectomy. In: Greene A, Slavin SA, Brorson H (eds) Lymphedema: presentation, diagnosis, and treatment. Springer, New York, pp 313–324
doi: 10.1007/978-3-319-14493-1_28
Ashforth K (2019) Identifying fibrosis in every stage of lymphedema. Lymphatic Education and Research Network. https://lymphaticnetwork.org/news-events/identifying-fibrosis-in-every-stage-of-lymphedema
Deng J, Lukens JN, Swisher-McClure S et al (2021) Photobiomodulation therapy in head and neck cancer-related lymphedema: a pilot feasibility study. Integr Cancer Ther 20:15347354211037938
pubmed: 34387119
pmcid: 8366198
doi: 10.1177/15347354211037938
Kataru RP, Wiser I, Baik JE et al (2019) Fibrosis and secondary lymphedema: chicken or egg? Transl Res 209:68–76
pubmed: 31022376
pmcid: 7400991
doi: 10.1016/j.trsl.2019.04.001
Beardsley C, Škarabot J (2015) Effects of self-myofascial release: a systematic review. J Bodyw Mov Ther 19(4):747–758
pubmed: 26592233
doi: 10.1016/j.jbmt.2015.08.007
Cheatham SW, Baker R, Kreiswirth E (2019) Instrument assisted soft-tissue mobilization: a commentary on clinical practice guidelines for rehabilitation professionals. Int J Sports Phys Ther 14(4):670
pubmed: 31440416
pmcid: 6670063
doi: 10.26603/ijspt20190670
Gott FH, Ly K, Piller N, Mangion A (2018) Negative pressure therapy in the management of lymphoedema. J Lymphoedema 13(1):43–48
Robijns J, Lodewijckxl J, Arany P et al (2022) Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front Oncol. https://doi.org/10.3389/fonc.2022927685
doi: 10.3389/fonc.2022927685
pubmed: 36110957
pmcid: 9468822
Zaleska MT, Olszewski WL (2019) The effectiveness of intermittent pneumatic compression in therapy of lymphedema of lower limbs: methods of evaluation and results. Lymphat Res Biol 17(1):60–69
pubmed: 30281381
doi: 10.1089/lrb.2018.0005
Suami H, Scaglioni MF (2018) Anatomy of the lymphatic system and the lymphosome concept with reference to lymphedema. Semin Plast Surg 32:5–11
pubmed: 29636647
pmcid: 5891651
doi: 10.1055/s-0038-1635118
Chang DW, Dayan J, Greene AK, MacDonald JK, Masia J, Mehrara B, Neligan PC, Nguyen D (2021) Surgical treatment of lymphedema: a systematic review and meta-analysis of controlled trials. Results of a consensus conference. Plast Reconstr Surg 23:10–97
Torrisi JS, Joseph WJ, Ghanta S, Cuzzone DA, Albano NJ, Savetsky IL, Gardenier JC, Skoracki R, Chang D, Mehrara BJ (2015) Lymphaticovenous bypass decreases pathologic skin changes in upper extremity breast cancer-related lymphedema. Lymphat Res Biol 13(1):46–53
pubmed: 25521197
pmcid: 4365441
doi: 10.1089/lrb.2014.0022
Chang DW, Suami H, Skoracki R (2013) A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 132:1305–1314
pubmed: 24165613
doi: 10.1097/PRS.0b013e3182a4d626
Boccardo FM, Casabona F, Friedman D, Puglisi M, De Cian F, Ansaldi F, Campisi C (2011) Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol 18(9):2500–2505
pubmed: 21369739
doi: 10.1245/s10434-011-1624-4
Chang DW, Dayan J, Greene AK, MacDonald JK, Masia J, Mehrara B, Neligan PC, Nguyen D (2021) Surgical treatment of lymphedema: a systematic review and meta-analysis of controlled trials. Results of a Consensus Conference. Plast Reconstr Surg 147(4):975–993
pubmed: 33761519
doi: 10.1097/PRS.0000000000007783
Dayan JH, Dayan E, Smith ML (2015) Reverse lymphatic mapping: a new technique for maximizing safety in vascularized lymph node transfer. Plast Reconstr Surg 135(1):277–285
pubmed: 25285683
doi: 10.1097/PRS.0000000000000822
Saaristo AM, Niemi TS, Viitanen TP, Tervala TV, Hartiala P, Suominen EA (2012) Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg 255(3):468–473
pubmed: 22233832
doi: 10.1097/SLA.0b013e3182426757
Lähteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, Lähteenvuo J, Kholová I, Alitalo K, Ylä-Herttuala S, Saaristo A (2011) Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation 123(6):613–620
pubmed: 21282502
doi: 10.1161/CIRCULATIONAHA.110.965384
Becker C, Vasile JV, Levine JL, Batista BN, Studinger RM, Chen CM, Riquet M (2012) Microlymphatic surgery for the treatment of iatrogenic lymphedema. Clin Plast Surg 39(4):385–398
pubmed: 23036289
doi: 10.1016/j.cps.2012.08.002
Dayan JH, Ly CL, Kataru RP, Mehrara BJ (2018) Lymphedema: pathogenesis and novel therapies. Annu Rev Med 69:263–276
pubmed: 28877002
doi: 10.1146/annurev-med-060116-022900
Schaverien MV, Munnoch DA, Brorson H (2018) Liposuction treatment of lymphedema. Semin Plast Surg 32:42–47
pubmed: 29636653
pmcid: 5891650
doi: 10.1055/s-0038-1635116
Brorson H (2016) Liposuction in lymphedema treatment. J Reconstr Microsurg 32(01):056–065
Ko DS, Lerner R, Klose G et al (1998) Effective treatment of lymphedema of the extremities. Arch Surg 133:452–458
pubmed: 9565129
doi: 10.1001/archsurg.133.4.452
Földi E, Földi M, Clodius L (1989) The lymphedema chaos: a lancet. Ann Plast Surg 22:505–515
pubmed: 2751222
doi: 10.1097/00000637-198906000-00007
Szuba A, Cooke JP, Yousuf S et al (2000) Decongestive lymphatic therapy for patients with cancer related or primary lymphedema. Am J Med 109:296–300
pubmed: 10996580
doi: 10.1016/S0002-9343(00)00503-9
McNeely ML, Magee DJ, Lees AW et al (2004) The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial. Breast Cancer Res Treat 86:95–106
pubmed: 15319562
doi: 10.1023/B:BREA.0000032978.67677.9f
Dionyssiou D, Demiri E, Tsimponis A, Sarafis A, Mpalaris V, Tatsidou G, Arsos G (2016) A randomized control study of treating secondary stage ii breast cancer-related lymphoedema with free lymph node transfer. Breast Cancer Res Treat 156(1):73–79
pubmed: 26895326
doi: 10.1007/s10549-016-3716-0
Nguyen D, Zaitseva TS, Zhou A, Rochlin D, Sue G, Deptula P, Tabada P, Wan D, Loening A, Paukshto M, Dionyssiou D (2022) Lymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds: preliminary preclinical and clinical results. J Surg Oncol 125(2):113–122
pubmed: 34549427
doi: 10.1002/jso.26679
Nguyen DH, Zhou A, Posternak V, Rochlin DH (2021) Nanofibrillar collagen scaffold enhances edema reduction and formation of new lymphatic collectors after lymphedema surgery. Plast Reconstr Surg 148(6):1382–1393
pubmed: 34705812
doi: 10.1097/PRS.0000000000008590
Rochlin DH, Inchauste S, Zelones J, Nguyen DH (2020) The role of adjunct nanofibrillar collagen scaffold implantation in the surgical management of secondary lymphedema: Review of the literature and summary of initial pilot studies. J Surg Oncol 121(1):121–128
pubmed: 31209884
doi: 10.1002/jso.25576
Huang NF, Okogbaa J, Lee JC, Jha A, Zaitseva TS, Paukshto MV, Sun JS, Punjya N, Fuller GG, Cooke JP (2013) The modulation of endothelial cell morphology, function, and survival using anisotropic nanofibrillar collagen scaffolds. Biomaterials 34:4038–4047
pubmed: 23480958
pmcid: 3695739
doi: 10.1016/j.biomaterials.2013.02.036
Nakayama KH, Hong G, Lee JC, Patel J, Edwards B, Zaitseva TS, Paukshto MV, Dai H, Cooke JP, Woo YJ, Huang NF (2015) Aligned-braided nanofibrillar scaffold with endothelial cells enhances arteriogenesis. ACS Nano 9(7):6900–6908
pubmed: 26061869
pmcid: 4757475
doi: 10.1021/acsnano.5b00545
Hadamitzky C, Zaitseva TS, Bazalova-Carter M, Paukshto MV, Hou L, Strassberg Z, Ferguson J, Matsuura Y, Dash R, Yang PC, Kretchetov S, Vogt PM, Rockson SG, Cooke JP, Huang NF (2016) Aligned nanofibrillar collagen scaffolds – guiding lymphangiogenesis for treatment of acquired lymphedema. Biomaterials 102:259–267
pubmed: 27348849
pmcid: 5157930
doi: 10.1016/j.biomaterials.2016.05.040
Swartz MA, Boardman KC Jr (2002) The role of interstitial stress in lymphatic function and lymphangiogenesis. Ann N Y Acad Sci 979:197–210 (discussion 229-34)
pubmed: 12543729
doi: 10.1111/j.1749-6632.2002.tb04880.x
Boardman KC, Swartz MA (2003) Interstitial flow as a guide for lymphangiogenesis. Circ Res 92(7):801–808
pubmed: 12623882
doi: 10.1161/01.RES.0000065621.69843.49
Yang CY, Tinhofer IE, Nguyen D, Cheng MH (2022) Enhancing lymphangiogenesis and lymphatic drainage to vascularized lymph nodes with nanofibrillar collagen scaffolds. J Surg Oncol 126(7):1169–1175
pubmed: 35950942
doi: 10.1002/jso.27058
Dionyssiou D, Nguyen D, Topalis A et al (2023) Treatment of rat lymphedema by propeller lymphatic tissue flap combined with nano-fibrillar collagen scaffolds. J Reconstr Microsurg. https://doi.org/10.1055/a-2086-0269
doi: 10.1055/a-2086-0269
pubmed: 37142251
Deptula P, Zhou A, Posternak V, He H, Nguyen D (2022) Multimodality approach to lymphedema surgery achieves and maintains normal limb volumes: a treatment algorithm to optimize outcomes. J Clin Med 11(3):598
pubmed: 35160049
pmcid: 8836570
doi: 10.3390/jcm11030598
Dionyssiou D, Demiri E (2021) A comprehensive treatment algorithm for patients requiring simultaneous breast and lymphedema reconstruction based on lymph node transfer. Ann Breast Surg 6:33
doi: 10.21037/abs-20-142
Brazio PS, Nguyen DH (2021) Combined liposuction and physiologic treatment achieves durable limb volume normalization in Class II-III lymphedema: a treatment algorithm to optimize outcomes. Ann Plast Surg 86(5S Suppl 3):S384–S389
pubmed: 33976067
doi: 10.1097/SAP.0000000000002695
Koelmeyer LA, Thompson BM, Mackie H, Blackwell R, Heydon-White A, Moloney E, Gaitatzis K, Boyages J, Suami H (2021) Personalizing conservative lymphedema management using indocyanine green-guided manual lymphatic drainage. Lymphat Res Biol 19(1):56–65
pubmed: 33270517
doi: 10.1089/lrb.2020.0090
Suami H, Thompson B, Mackie H, Blackwell R, Heydon-White A, Blake FT, Boyages J, Koelmeyer L (2022) A new indocyanine green fluorescence lymphography protocol for diagnostic assessment of lower limb lymphoedema. J Plast Reconstr Aesthet Surg 75(11):3946–3955
pubmed: 36192315
doi: 10.1016/j.bjps.2022.08.017
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390
pubmed: 31626055
pmcid: 8576825
doi: 10.1249/MSS.0000000000002116
Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, McCarthy S, Murnane A, Patchell S, Adams D (2018) Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust 209(4):184–187
pubmed: 29719196
doi: 10.5694/mja18.00199
Segal R, Zwaal C, Green E, Tomasone JR et al (2017) Exercise for People with Cancer Guideline Development, Exercise for people with cancer: a clinical practice guideline. Curr Oncol 24(1):40–46
pubmed: 28270724
pmcid: 5330628
doi: 10.3747/co.24.3376
Cramp F, Byron-Daniel J (2012) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 11:CD006145
pubmed: 23152233
Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):87–100
pubmed: 20052559
doi: 10.1007/s11764-009-0110-5
Fong DY, Ho JW, Hui BP, Lee AM, Macfarlane DJ, Leung SS, Cerin E, Chan WY, Leung IP, Lam SH, Taylor AJ, Cheng KK (2012) Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ 344:e70
pubmed: 22294757
pmcid: 3269661
doi: 10.1136/bmj.e70
van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK (2015) Effect of Low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES Randomized Clinical Trial. J Clin Oncol 33(17):1918–1927
pubmed: 25918291
doi: 10.1200/JCO.2014.59.1081
Courneya KS, Segal RJ, Mackey JR et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404
pubmed: 17785708
doi: 10.1200/JCO.2006.08.2024
Mijwel S, Bolam KA, Gerrevall J, Foukakis T, Wengström Y, Rundqvist H (2020) Effects of exercise on chemotherapy completion and hospitalization rates: the OptiTrain Breast Cancer Trial. Oncologist 25(1):23–32
pubmed: 31391297
doi: 10.1634/theoncologist.2019-0262
Ibrahim EM, Al-Homaidh A (2011) Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol 28(3):753–765
pubmed: 20411366
doi: 10.1007/s12032-010-9536-x
Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29(6):726–732
pubmed: 21205749
pmcid: 3056656
doi: 10.1200/JCO.2010.31.5226
Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104(11):815–840
pubmed: 22570317
pmcid: 3465697
doi: 10.1093/jnci/djs207
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS (2006) Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24(22):3527–3534
pubmed: 16822844
doi: 10.1200/JCO.2006.06.0855
Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24(22):3535–3541
pubmed: 16822843
doi: 10.1200/JCO.2006.06.0863
Johansson K, Hayes S (2020) A historical account of the role of exercise in the prevention and treatment of cancer-related lymphedema. Lymphology 53(2):55–62
pubmed: 33190428
doi: 10.2458/lymph.4655
Nelson NL (2016) Breast cancer-related lymphedema and resistance exercise: a systematic review. J Strength Cond Res 30(9):2656–2665
pubmed: 26840439
doi: 10.1519/JSC.0000000000001355
Buchan J, Janda M, Box R, Rogers LQ, Hayes S (2022) Self-efficacy to overcome exercise barriers in individuals with cancer-related lymphedema. Lymphology 55(1):10–20
pubmed: 35896111
doi: 10.2458/lymph.5140
Schmitz KH (2010) Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors. Exerc Sport Sci Rev 38(1):17–24
pubmed: 20016295
pmcid: 2800982
doi: 10.1097/JES.0b013e3181c5cd5a
Dasso NA (2019) How is exercise different from physical activity? A concept analysis. Nurs Forum 54(1):45–52
pubmed: 30332516
doi: 10.1111/nuf.12296
American College of Sports Medicine (2017) ACSM’s guidelines for exercise testing and prescription, 10th edn. Wolters Kluwer Health, Philadelphia
Yildiz Kabak V, Gursen C, Aytar A, Akbayrak T, Duger T (2021) Physical activity level, exercise behavior, barriers, and preferences of patients with breast cancer-related lymphedema. Support Care Cancer 29(7):3593–3602
pubmed: 33170403
doi: 10.1007/s00520-020-05858-3
U.S. Department of Health and Human Services (2018) 1. Physical activity guidelines for Americans, 2nd ed
Courneya KS, Friedenreich CM (2001) Framework PEACE: an organizational model for examining physical exercise across the cancer experience. Ann Behav Med 23(4):263–272
pubmed: 11761343
doi: 10.1207/S15324796ABM2304_5
Baumann FT, Reike A, Reimer V, Schumann M, Hallek M, Taaffe DR, Newton RU, Galvao DA (2018) Effects of physical exercise on breast cancer-related secondary lymphedema: a systematic review. Breast Cancer Res Treat 170(1):1–13
pubmed: 29470804
doi: 10.1007/s10549-018-4725-y
Hayes SC, Singh B, Reul-Hirche H, Bloomquist K, Johansson K, Jonsson C, Plinsinga ML (2022) The effect of exercise for the prevention and treatment of cancer-related lymphedema: a systematic review with meta-analysis. Med Sci Sports Exerc 54(8):1389–1399
pubmed: 35320145
doi: 10.1249/MSS.0000000000002918
Hasenoehrl T, Palma S, Ramazanova D, Kolbl H, Dorner TE, Keilani M, Crevenna R (2020) Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis. Support Care Cancer 28(8):3593–3603
pubmed: 32415386
pmcid: 7316683
doi: 10.1007/s00520-020-05521-x
Hasenoehrl T, Keilani M, Palma S, Crevenna R (2020) Resistance exercise and breast cancer related lymphedema - a systematic review update. Disabil Rehabil 42(1):26–35
pubmed: 30638093
doi: 10.1080/09638288.2018.1514663
National Lymphedema Network (2011) Position Statement of the National Lymphedema Network: Topic: The Diagnosis and Treatment of Lymphedema. https://lymphnet.org/position-papers
Onazi MMA, Campbell KL, Mackey JR, McNeely ML (2023) Benefits of combined upper body exercise and compression therapy for breast cancer related lymphedema: a systematic review. Physiother Can. https://doi.org/10.3138/ptc-2022-0009
doi: 10.3138/ptc-2022-0009
Greene AK, Slavin S, Brorson H (2015) The lymphedema center and multidisciplinary management. In: Greene AK, Slavin S, Brorson H (eds) Lymphedema - presentation, diagnosis, and treatment. Springer, Cham, pp 51–55
doi: 10.1007/978-3-319-14493-1_6